Back
Organon & Co. 10K Form
Buy
64
OGN
Organon & Co.
Last Price:
$7.14
Seasonality Move:
22.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OGN News And Ratings
See the #1 stock for the next 7 days that we like better than OGN
OGN Financial Statistics
Sales & Book Value
| Annual Sales: | $6.4B |
|---|---|
| Cash Flow: | $149M |
| Price / Cash Flow: | 3.17 |
| Annual Sales: | $3.48 |
| Price / Book: | 2.09 |
Profitability
| EPS (TTM): | 1.92390 |
|---|---|
| Net Income (TTM): | $501M |
| Gross Margin: | $3.7B |
| Return on Equity: | 79.63% |
| Return on Assets: | 3.79% |
Organon & Co. Earnings Forecast
Key Organon & Co. Financial Ratios
-
The Gross Profit Margin over the past 8 years for OGN is 58.02%.
-
The Selling, General & Administrative Expenses for OGN have been equal to 27.49% of Gross Profit Margin.
-
The Research & Development expenses have been 7.32% of Revenue.
-
The Interest Expense is 61.23% of Operating Income.
-
The Net Earning history of OGN is 13.49% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 3 years.
Organon & Co. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | OGN |
| Website: | organon.com |
Debt
| Debt-to-Equity Ratio: | 9.74 |
|---|---|
| Current Ratio: | 1.75 |
| Quick Ratio: | 0.81 |
Price-to-Earnings
| Trailing P/E Ratio: | 2.18 |
|---|---|
| Forward P/E Ratio: | 1.85 |
OGN Technical Analysis vs Fundamental Analysis
Buy
64
Organon & Co. (OGN)
is a Buy
Is Organon & Co. a Buy or a Sell?
-
Organon & Co. stock is rated a BuyThe current Organon & Co. [OGN] share price is $7.27. The Score for OGN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.